Filter
58
Text search:
Guillain-Barrè
Syndrome
Featured
Recommendations
5
New Publications
36
Language
Document type
No document type
47
Studies & Reports
3
Guidelines
3
Fact sheets
3
Manuals
1
Training Material
1
Countries / Regions
India
5
Brazil
3
Philippines
2
Colombia
2
Zimbabwe
1
Nepal
1
Germany
1
Kenya
1
Indonesia
1
South Africa
1
Bangladesh
1
Mozambique
1
Dominican Republic
1
Honduras
1
Angola
1
Cape Verde
1
Latin America and the Carribbean
1
Western and Central Europe
1
Paraguay
1
Venezuela
1
Italy
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
21
Clinical Guidelines
2
Toolboxes
Zika
31
COVID-19
8
Rapid Response
3
NTDs
2
Refugee
1
Mental Health
1
Management of Snake Bite. Quick Reference Guide
recommended
Standard Treatment Guideline
Stand 2.10.2020
Bulletin of the World Health Organization 2016. doi: http://dx.doi.org/10.2471/BLT.16.171082
Objective: To describe the temporal and geographical distribution of Zika virus infection, and associated neurological disorders, from 1947 to February 2016.
Standard Treatment Guideline
updated 05 April 2016
Snakebite is an acute life threatening time limiting medical emergency. It is a preventable public
health hazard often faced by rural population in tropical and subtropical countries with heavy
rainfall and humid climate.
This is a resource pack for a Knowledge, Attitudes and Practices (KAP) surveys about Zika virus and its suspected complications such as microcephaly and Guillain-Barré
...
Updated 6 September 2016. This guidance has been developed to provide advice on the prevention of potential sexual transmission of Zika virus. The primary transmission route of Zika virus is via the Aedes mosquito. However, sexual transmission of Zika virus may also be possible, with limited evidenc
...
29 September 2021
The objective of this document is to guide the preparation and implementation of national preparedness plans for the safety of substances of human origin during outbreaks of Zika virus infection, both in affected and non-affected areas.
6 June 2022
These WHO interim recommendations on the use of the Janssen Ad26.COV2.S (COVID-19) vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
Th
...
4ª edição
Nos próximos meses, a COVID Reference apresentará atualizações regulares e narrará os dados científicos o mais coerente possível.
Int J Crit Illn Inj Sci. 2012 May-Aug; 2(2): 82–97.
doi: 10.4103/2229-5151.97273
PMCID: PMC3401822
PMID: 22837896
